Immunotherapy has transformed the field of oncology by harnessing the immune system’s innate ability to mount targeted attacks on cancer cells. Building on this foundation, cell and gene therapies take immunotherapy to the next level by reprogramming genetic blueprints and engineering immune cells to deliver highly personalized, possibly curative treatments. Together, these innovations could dramatically improve outcomes, with the potential to transform cancer into a more manageable condition — or even eliminate it.